Optimal management strategies for primary HPV testing for cervical screening: cost-effectiveness evaluation for the National Cervical Screening Program in Australia

KT Simms, M Hall, MA Smith, JB Lew, S Hughes… - PLoS …, 2017 - journals.plos.org
Background Several countries are implementing a transition to HPV testing for cervical
screening in response to the introduction of HPV vaccination and evidence indicating that …

[HTML][HTML] Effectiveness and costs of an implemented primary HPV cervical screening programme in Sweden–A population based cohort study

L Bergengren, L Ryen, C Flodström, H Fadl… - Preventive Medicine …, 2022 - Elsevier
Swedish guidelines recommend cervical screening with primary HPV for women≥ 30 years
of age. The aim of this study was to compare an implemented HPV cervical screening …

Benefits and potential harms of human papillomavirus (HPV)‐based cervical cancer screening: A real‐world comparison of HPV testing versus cytology

LT Thomsen, SK Kjær, C Munk… - Acta Obstetricia et …, 2021 - Wiley Online Library
Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows

CJJ Huijsmans, WRR Geurts-Giele, C Leeijen… - BMC cancer, 2016 - Springer
Background Primary high risk (hr) HPV screening will be introduced in The Netherlands in
January 2017. Our aim was to determine the hrHPV prevalence in the Dutch cervical cancer …

Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study

EEL Jansen, IMCM de Kok, S Kaljouw, E Demirel… - BMC medicine, 2022 - Springer
Background Human papillomavirus (HPV) vaccination and intensifying screening expedite
cervical cancer (CC) elimination, yet also deteriorate the balance between harms and …

Evaluation of 14 triage strategies for HPV DNA‐positive women in population‐based cervical screening

DC Rijkaart, J Berkhof… - … journal of cancer, 2012 - Wiley Online Library
High‐risk human papillomavirus (hrHPV) testing has a higher sensitivity but lower specificity
than cytology for detection of high‐grade intraepithelial neoplasia (CIN). To avoid over …

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of …

MG Dijkstra, M van Zummeren, L Rozendaal… - bmj, 2016 - bmj.com
Objectives To provide an early risk assessment of extending screening intervals beyond five
years for a human papillomavirus (HPV) based cervical screening programme in the …

Comparative accuracy of cervical cancer screening strategies in healthy asymptomatic women: a systematic review and network meta-analysis

T Terasawa, S Hosono, S Sasaki, K Hoshi… - Scientific reports, 2022 - nature.com
To compare all available accuracy data on screening strategies for identifying cervical
intraepithelial neoplasia grade≥ 2 in healthy asymptomatic women, we performed a …

[HTML][HTML] Impact of variations in triage cytology interpretation on human papillomavirus–based cervical screening and implications for screening algorithms

G Ronco, M Zappa, S Franceschi, S Tunesi… - European Journal of …, 2016 - Elsevier
Background Women positive to human papillomavirus (HPV+) testing at cervical screening
need triage, typically cytology and immediate colposcopy in case of atypical squamous cells …

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance

WK Huh, KA Ault, D Chelmow, DD Davey… - Journal of lower …, 2015 - journals.lww.com
In 2011, the American Cancer Society, the American Society for Colposcopy and Cervical
Pathology, and the American Society for Clinical Pathology updated screening guidelines …